Avid Bioservices, Inc. - CDMO Market Value

Avid Bioservices, Inc. (CDMO) relies on the creation of highly complex protein structures and antibodies, serving as a technological hub for the largest pharmaceutical companies. A high barrier to entry is ensured by expensive equipment and strict FDA standards, making a change of supplier nearly impossible. Current market capitalization stands at 0.80. This price chart on the GURU.Markets platform demonstrates the stock dynamics of this reliable partner, known for its perfect compliance with production regulations.

CDMO Avid Bioservices: Market Value in the range 07/04/2022 - 02/16/2025

Comprehensive metric breakdowns and analytics for Avid Bioservices, Inc. (CDMO)

- current price and projected stock value:

Stock Price Avid Bioservices, Inc.|CDMO - Broker Consensus Forecast

- issuer market value details:

Market Value Avid Bioservices Inc.|CDMO - Real Price to Acquire Entire Company

- book value of equity indicators:

Net Assets per Single Share Avid Bioservices|CDMO - Total Stockholders' Equity|Market Value to Book Value Ratio avidbio.com|CDMO - Total Asset Value of Company

- debt level and financial liquidity data:

- business earnings and investment ratios data:

CDMO - Net Profit|Future Profit Avid Bioservices, Inc.|CDMO - Company Value to Net Income|Projected Price to Earnings Avid Bioservices, Inc|CDMO - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Avid Bioservices Inc|CDMO - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Avid Bioservices|CDMO - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months avidbio.com|CDMO - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Avid Bioservices, Inc.

- revenue and sales details:

CDMO - Company Gross Revenue|Projected Sales Volume Avid Bioservices Inc.|CDMO - P/S Multiple|Forward Price-to-Revenue Multiple Avid Bioservices, Inc.

Fundamental company analysis:CDMO (Avid Bioservices, Inc)

Avid Bioservices, Inc. (CDMO) generates revenue through complex contract manufacturing of antibodies and vaccines for the global biopharmaceutical sector. Market capitalization represents the aggregate value of all shares, reflecting the current exchange consensus regarding the business. This metric allows for an assessment of the enterprise's scale and the timely identification of systemic asset degradation. The company's market valuation history captures the dynamics of investor confidence in long-term B2B contracts. Analyzing the chart helps avoid value traps when selecting a strategy.

Key competitors